Page 72 - 2020_11-Haematologica-web

M. Gooptu and J. Koreth
treatment of graft-versus-host disease. Curr
Oncol. 2010;17(2):55-58.
98. Flowers MED, Apperley JF, van Besien K, et
al. A multicenter prospective phase 2 ran- domized study of extracorporeal photo- pheresis for treatment of chronic graft-ver- sus-host disease. Blood. 2008;112(7):2667- 2674.
99. Greinix HT, Volc-Platzer B, Rabitsch W, et al. Successful use of extracorporeal pho- tochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood. 1998;92(9):3098-3104.
100. Perfetti P, Carlier P, Strada P, et al. Extracorporeal photopheresis for the treat- ment of steroid refractory acute GVHD. Bone Marrow Transplant. 2008;42(9):609- 617.
101. Paczesny S, Krijanovski OI, Braun TM, et al. A biomarker panel for acute graft-versus- host disease. Blood. 2009;113(2):273-278.
102. Paczesny S, Braun T, Lugt MV, et al. A three biomarker panel at days 7 and 14 can predict
development of grade II-IV acute graft-ver- sus-host disease. Biol Blood Marrow Transplant. 2011;17(2):S167.
103. Major-Monfried H, Renteria AS, Pawarode A, et al. MAGIC biomarkers predict long- term outcomes for steroid-resistant acute GVHD. Blood. 2018;131(25):2846-2855.
104.Newell LF, Defor TE, Cutler CS, et al. Follistatin and endoglin: potential biomark- ers of endothelial damage and non-relapse mortality after myeloablative allogeneic hematopoietic cell transplantation in Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0402. Biol Blood Marrow Transplant. 2017;23(3):S73-S74.
105. Staffas A, Burgos da Silva M, van den Brink MRM. The intestinal microbiota in allogene- ic hematopoietic cell transplant and graft- versus-host disease. Blood. 2017;129(8):927- 933.
106. Ivanov II, Atarashi K, Manel N, et al. Induction of intestinal Th17 cells by seg- mented filamentous bacteria. Cell. 2009;139
(3):485-498.
107.Jenq RR, Taur Y, Devlin SM, et al.
Intestinal blautia is associated with reduced death from graft-versus-host dis- ease. Biol Blood Marrow Transplant. 2015;21(8):1373-1383.
108. Peled JU, Gomes ALC, Devlin SM, et al. Microbiota as predictor of mortality in allo- geneic hematopoietic-cell transplantation. N Engl J Med. 2020;382(9):822-834.
109.vanLierYF,DavidsM,HaverkateNJE,etal. Fecal microbiota transplantation can cure steroid-refractory intestinal graft-versus- host disease. Biol Blood Marrow Transplant. 2019;25(3):S241.
110. Qi X, Li X, Zhao Y, et al. Treating steroid refractory intestinal acute graft-vs.-host dis- ease with fecal microbiota transplantation: a pilot study. Front Immunol. 2018;9:2195.
111.DeFilipp Z, Bloom PP, Torres Soto M, et al. Drug-resistant E. coli bacteremia transmit- ted by fecal microbiota transplant. N Engl J Med. 2019;381(21):2043-2050.
2560
haematologica | 2020; 105(11)